Total Payments
$108,134
2024 Payments
$0
Companies
12
Transactions
39
Medicare Patients
2,664
Medicare Billing
$696,862
Payment Breakdown by Category
Gifts$96,045 (88.8%)
Other$10,923 (10.1%)
Food & Beverage$1,166 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $96,045 | 3 | 88.8% |
| Current or prospective ownership or investment interest | $10,923 | 6 | 10.1% |
| Food and Beverage | $1,166 | 22 | 1.1% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
General
$108,134
31 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $96,155 | 4 | $0 (2020) |
| US Retina LLC | $10,923 | 14 | $0 (2024) |
| LENSAR, Inc. | $375.72 | 4 | $0 (2019) |
| Allergan, Inc. | $266.35 | 9 | $0 (2022) |
| Alcon Laboratories Inc | $149.23 | 1 | $0 (2018) |
| Alimera Sciences, Inc. | $128.32 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $32.34 | 1 | $0 (2019) |
| Genentech, Inc. | $30.52 | 1 | $0 (2018) |
| Carl Zeiss Meditec, Inc. | $19.15 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $19.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 1 | US Retina LLC |
| 2023 | $0 | 1 | US Retina LLC |
| 2022 | $4,696 | 5 | US Retina LLC ($4,655) |
| 2021 | $2,928 | 3 | US Retina LLC ($2,928) |
| 2020 | $52,704 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($51,200) |
| 2019 | $47,411 | 14 | Bausch & Lomb, a division of Bausch Health US, LLC ($44,955) |
| 2018 | $247.97 | 7 | Alcon Laboratories Inc ($149.23) |
| 2017 | $147.40 | 3 | Alimera Sciences, Inc. ($128.32) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 2023 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/22/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/13/2022 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $4,047.90 | General |
| 04/12/2022 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $607.00 | General |
| 01/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| Category: FACIAL AESTHETICS | ||||||
| 2022 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 05/11/2021 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $2,542.50 | General |
| 05/06/2021 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $385.62 | General |
| 2021 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/31/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS PC (Device) | Gift | In-kind items and services | $51,200.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2020 | Allergan, Inc. | DURYSTA (Drug) | Gift | In-kind items and services | $45.00 | General |
| Category: GLAUCOMA | ||||||
| 07/22/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: GLAUCOMA | ||||||
| 03/13/2020 | US Retina LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,444.55 | General |
| 2020 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/31/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS PC (Device) | Gift | In-kind items and services | $44,800.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.34 | General |
| 10/11/2019 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $136.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/03/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS PC (Device) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/04/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $124.86 | General |
| 05/03/2019 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $35.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2019 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $193.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2019 | Carl Zeiss Meditec, Inc. | VisuMax (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Surgical Optical Laser | ||||||
| 03/07/2019 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Optics | ||||||
| 02/21/2019 | US Retina LLC | — | Current or prospective ownership or investment interest | Stock option | $1,895.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 16 | 821 | 2,496 | $359,593 | $158,974 |
| 2021 | 18 | 1,130 | 3,187 | $559,849 | $277,330 |
| 2020 | 19 | 713 | 2,380 | $665,310 | $260,558 |
Total Patients
2,664
Total Services
8,063
Medicare Billing
$696,862
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2022 | 165 | 463 | $69,450 | $41,996 | 60.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 12 | 156 | $62,400 | $36,536 | 58.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 44 | 215 | $64,500 | $19,690 | 30.5% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2022 | 68 | 80 | $41,600 | $16,479 | 39.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 41 | 175 | $17,500 | $12,719 | 72.7% |
| 92134 | Imaging of retina | Office | 2022 | 130 | 339 | $33,900 | $10,540 | 31.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 77 | 108 | $14,580 | $5,253 | 36.0% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 37 | 38 | $9,500 | $4,113 | 43.3% |
| 92250 | Photography of the retina | Office | 2022 | 95 | 120 | $12,182 | $2,988 | 24.5% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2022 | 15 | 61 | $7,625 | $2,677 | 35.1% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2022 | 44 | 45 | $13,755 | $2,331 | 17.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 30 | 43 | $3,225 | $1,231 | 38.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 15 | 15 | $3,000 | $1,031 | 34.4% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 21 | 23 | $2,346 | $630.01 | 26.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 601 | $3,005 | $549.02 | 18.3% |
| 67820 | Removal of eyelashes using forceps | Office | 2022 | 12 | 14 | $1,025 | $209.51 | 20.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 215 | 615 | $92,250 | $59,014 | 64.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 21 | 76 | $79,200 | $51,481 | 65.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 14 | 185 | $72,000 | $45,983 | 63.9% |
| 67028 | Injection of drug into eye | Office | 2021 | 64 | 349 | $104,700 | $33,885 | 32.4% |
| 92242 | Imaging of blood vessels in back of eye using fluorescein and indocyanine-green dye | Office | 2021 | 84 | 96 | $49,920 | $20,929 | 41.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2021 | 53 | 272 | $27,200 | $20,249 | 74.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 159 | 473 | $47,300 | $15,407 | 32.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 100 | 140 | $18,900 | $7,092 | 37.5% |
| 92250 | Photography of the retina | Office | 2021 | 151 | 196 | $17,243 | $5,802 | 33.6% |
About Dr. Michael Bennett, M.D
Dr. Michael Bennett, M.D is a Ophthalmology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043274111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bennett, M.D has received a total of $108,134 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 39 transactions from 12 companies. The most common payment nature is "Gift" ($96,045).
As a Medicare-enrolled provider, Bennett has provided services to 2,664 Medicare beneficiaries, totaling 8,063 services with total Medicare billing of $696,862. Data is available for 3 years (2020–2022), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Honolulu, HI
- Active Since 04/14/2006
- Last Updated 03/20/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1043274111
Products in Payments
- STELLARIS PC (Device) $96,030
- LENSAR LASER SYSTEM (Device) $375.72
- LenSx (Device) $149.23
- Iluvien (Biological) $128.32
- LUMIGAN (Drug) $115.59
- DURYSTA (Drug) $59.40
- COMBIGAN (Drug) $57.02
- Lucentis (Biological) $30.52
- BOTOX (Biological) $23.14
- VisuMax (Device) $19.15
- PROLENSA (Drug) $19.08
- Tecnis 1-piece IOL (Device) $18.61
- VABYSMO (Drug) $17.47
- ALPHAGAN P (Drug) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Honolulu
Dr. Neda Nikpoor, M.d, M.D
Ophthalmology — Payments: $226,642
Ophthalmology $226,642
Dr. Alan Faulkner, M.d, M.D
Ophthalmology — Payments: $164,314
Ophthalmology $164,314
Dr. Carlton Yuen, M.d, M.D
Ophthalmology — Payments: $125,416
Ophthalmology $125,416
Rupa Wong, M.d, M.D
Ophthalmology — Payments: $58,710
Ophthalmology $58,710
Dr. Jon Portis, M.d, M.D
Ophthalmology — Payments: $23,152
Ophthalmology $23,152
Dr. Eugene Ng, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $19,455
Ophthalmology $19,455